Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-123186

SVP, Chief Scientific Officer sold 50,000 shares at $4.89 ($244,500)

  • SVP, Chief Scientific Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Abrahmsen Lars B. · SVP, Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-01 Exercise or conversion : show line 1 in the form +50,000 $0.92 $46,000 69,000 D
2021-10-01 Sale : show line 2 in the form −50,000 $4.89 $244,500 19,000 D
Open-market sales · 50,000 sh · avg $4.89 · $244,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-01 Exercise or conversion : show line 3 in the form Stock Option (right to Buy) −50,000 30,587 D
Loading xslF345X03/tm2129205-2_4seq1.xml…